ABSTRACT To compare the hemodynamic effects of a calcium-channel blocker with those of a conventional vasodilator in the awake preinstrumented dog, diltiazem and nitroprusside were administered in equihypotensive infusions before (decrease in mean aortic pressure by 10%; p < .001, n = 6) and after (decrease in mean aortic pressure by 12%; p < .001) chronic volume overload (CVO) produced by an infrarenal aortocaval fistula. Diltiazem had no effect on preload either before or after CVO. The maximal rate of change in left ventricular pressure (dP/dtmax) was unaffected by diltiazem before the aortocaval fistula (decrease in dP/dtmax by 6%; p = NS) but was significantly reduced by calcium-channel blockade after CVO (decrease in dP/dtmax by 22%; p < .001). By contrast, at matched aortic pressures nitroprusside significantly reduced left ventricular end-diastolic dimension (LVEDD) and pressure (LVEDP) No. 3, 685-692, 1983. DILTIAZEM, a calcium-channel blocker, has two major potential direct hemodynamic effects: coronary and peripheral arterial vasodilation and myocardial depression. In addition to these direct effects, reflex sympathetic stimulation, induced by peripheral vasodilation, may offset or mask the negative inotropic and chronotropic effects of calcium-channel blockade. 14 However, net cardiocirculatory response to such drugs may be markedly different in the presence of congestive heart failure with its variable alterations in level of sympathetic reserve. Several clinical investigations detailing the beneficial effects of calcium-channel blockade as a means of vasodilator therapy for congestive heart failure have appeared.7-'0 However, acute pulmonary ede-
DILTIAZEM, a calcium-channel blocker, has two major potential direct hemodynamic effects: coronary and peripheral arterial vasodilation and myocardial depression. In addition to these direct effects, reflex sympathetic stimulation, induced by peripheral vasodilation, may offset or mask the negative inotropic and chronotropic effects of calcium-channel blockade. 14 However, net cardiocirculatory response to such drugs may be markedly different in the presence of congestive heart failure with its variable alterations in level of sympathetic reserve. Several clinical investigations detailing the beneficial effects of calcium-channel blockade as a means of vasodilator therapy for congestive heart fail-with reduced cardiac output after 20 to 30 mg of oral nifedipine have been reported. 12 By contrast, there are no investigations detailing the hemodynamic actions of diltiazem, which in equimolar doses has the least negative inotropic effects in vivo'-"' and in vivo6 of the clinically available drugs, in experimental or clinical heart failure. Furthermore, the comparative effects of afterload reduction by calcium-channel blockade and conventional vasodilators have not been assessed.
We therefore used an animal model for chronic volume overload (CVO) to assess the peripheral and myocardial effects of diltiazem before and after the onset of congestive heart failure. To study potential negative inotropic effects of this drug independent of the direct and reflex effects of peripheral arterial vasodilation, we chose to compare its effects with those of nitroprusside, a widely used vasodilator without direct myocardial actions. 16 The potency, rapid onset of action, and short half-life of this drug permitted us to precisely match the reduction in mean arterial pressure induced by diltiazem in the same animal before and after aortocaval fistula.
Methods
Surgical instrumentation. Six mongrel dogs, weighing 18 to 30 kg, were surgically instrumented (figure 1) for long-term physiologic monitoring by methods previously described for this laboratory. 17 Specifically, a left thoracotomy was performed under halothane (l.5%) anesthesia with xylazine and sodium pentobarbital induction (figure 1). We placed 16- 
Results
Control data. Baseline hemodynamic parameters in animals before construction of aortocaval fistula during control runs before diltiazem and nitroprusside differed only in that the heart rate was slightly higher before nitroprusside (72 + 7 vs 82 ± 7 beats/min; p < .05). In experiments performed after construction of aortocaval fistula, there was no significant difference in any parameter between the prediltiazem and prenitroprusside controls (table 1) .
Effects of aortocaval fistula. Hemodynamic changes produced by the construction of aortocaval fistulae appear in table 2 and are evident in figures 2 through 5. Significant increases in heart rate (before aortocaval fistula = 77 ± 7 beats/min vs after aortocaval fistula = 131 + 7 beats/min; p < .001), LVEDD (before aortocoval fistula = 42.4 + 1.7 mm vs after aortocaval fistula = 45.1 + 1.5 mm; p < .01), LVEDP (before aortocaval fistula = 8 + 1 mm Hg vs after aortocaval fistula = 13 + 2 mm Hg; p < .01), and %AD (before aortocaval fistula = 19 + 1%, after aortocaval fistula = 23 + 2%; p < .01), and a decline in aortic diastolic blood pressure (before aortocaval fistula = 68 + 2 mm Hg, after aortocaval fistula = 49 ± 2 mm Hg; p < .01) were observed. The dP/dtm., also increased significantly after aortocaval fistula from 2590 ± 260 to 3519 + 323 mm Hg/sec (p < .01).
Drug effects before and after aortocaval fistula. Figure 3 shows selected portions of analog recordings made of typical experiments during steady-state infusions of equihypotensive doses of diltiazem and nitroprusside in a single dog before and after aortocaval fistula.
Diltiazem had no effect on dP/dtm. before aortocaval fistula but depressed dP/dtma, from 3650 to 2883 mm Hg/sec after AV fistula. In addition, the calcium-channel blocker had no effect on LVEDD or LVEDP before or after CVO. By contrast, nitroprusside before and after aortocaval fistula reduced preload but had no effect on dP/dtma. reduction in dP/dtm. produced by diltiazem after CVO, the percent shortening of the minor diameter signal was unchanged by the drug in both circulatory states (19 + 1% before and after diltiazem before aortocaval fistula; 23 2% before and after the drug after aortocaval fistula).
Discussion
The results of this investigation confirm the hypothesis that the net hemodynamic effect of calcium-channel blockade on left ventricular performance depends on the circulatory state in which it is used.
Our data indicate that diltiazem, the calcium blocker Time (min) FIGURE 6 . Left ventricular dP/dt was unchanged during nitroprusside before or after AV fistula. By contrast, diltiazem produced no change before but a marked decline (20%) in dP/dt in the same animals after
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that has been shown in vivo6 and in vitro'3-15 to possess the least negative inotropic effects of the available drugs, is capable of producing substantial reductions in dP/dtmax when given parenterally to the conscious preinstrumented dog during CVO effected by the creation of an aortocaval fistula. Despite significant depression of dP/dtm~, the extent of myocardial fiber shortening as reflected by percent shortening of the ultrasonic left ventricular minor diameter crystals (%AD) was unaffected by the amount of diltiazem used in this study. The absence of a significant decline in percent of minor diameter shortening despite a substantial reduction in dP/dtm. in response to diltiazem after AV fistula may be explained by the increased sensitivity to changes in inotropic state and relative independence of loading conditions of isovolumetric (dP/dt) as compared with ejection phase indices (%AD) previously observed in the conscious preinstrumented animal2l1 22 and in man.23 Specifically, the calcium blocker-induced reduction in systemic arterial pressure may have offset the direct effects of the drug on extent of shortening. By contrast, the same dose of diltiazem given to the same animals before the circulatory congestion imposed by volume overload was without discernible effect on either isovolumetric or ejection phase measures of left ventricular function.
The diltiazem-induced reduction in dP/dtmax was not observed before or after CVO when nitroprusside, a vasodilator without direct myocardial effects,"6 was used in the same animals to produce decreases in systemic arterial pressure equal to those obtained with the calcium blocker. In addition, the calcium-channel blocker produced no discernible effect upon left ventricular preload before of after AV fistula, whereas equihypotensive infusions of nitroprusside significantly reduced transverse LVEDD and LVEDP before and after CVO. These results suggest that relative to nitroprusside, diltiazem is primarily a systemic arteriolar vasodilator without important effects upon venous capacitance. Nitroprusside was given a minimum of 30 min after diltiazem by study design to precisely match the calcium entry blocker-mediated systemic arterial vasodilation. Although the elimination of half-life of diltiazem is 2.24 hr in the dog,30 it is unlikely that possible residual plasma or tissue levels of this drug affected the observed changes produced by nitroprusside since all hemodynamic parameters had returned to control levels before conventional vasodilation, and we are unaware of any pharmacodynamic interaction between the two drugs.
The previous hemodynamic characterizations of this animal model of CVO suggests several potential explanations for the discrepant effects of diltiazem on left ventricular function observed before and after creation of the aortocaval fistula.2427 During the first few weeks after AV fistula formation, circulatory congestion is shown by pulmonary rales, ascites, and peripheral edema. The hemodynamic basis for these changes observed in this study included significant increases in heart rate and in left ventricular diameter and pressure (table 2) . Previous investigators have noted reduced systemic vascular resistance due to a threefold increase in cardiac output of which 55% is shunted from left to right at the level of the aortocaval fistula.25 Thus, this preparation constitutes a model of high-output congestive heart failure. Myocardial performance is known to be normal to enhanced in these dogs as indicated by the 22% increase in percent of left ventricular minor diameter shortening that we observed ( Several potential mechanisms may be evoked to explain the myocardial depression produced by diltiazem after CVO given the aforementioned direct and reflex circulatory adjustments that occur in this model. First, the high resting level of sympathetic tone and low peripheral vascular resistance after AV fistula may have prevented short-term reflex adaptation to calcium-channel blockade and hence unmasked the direct myocardial depressant effect shared by these compounds. Similarly, the absence of a significant reflex increase in heart rate after systemic vasodilation by diltiazem and nitroprusside after AV fistula in contrast to the reflex tachycardia evoked by both drugs before AV fistula, may be a consequence of the elevated basal sympathetic tone produced by CVO. Indeed, heart rate actually declined ( 
